Clean Yield Group Intercept Pharmaceuticals, Inc. Transaction History

Clean Yield Group

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 27, 2021	SELL	$12.99 - $20.47 $9,222 - $14,533	-710 Closed	0 $0
Q2 2021 Jul 26, 2021	BUY	$15.46 - $24.5 $10,976 - $17,395	710 New	710 $14,000
Q1 2021 Apr 26, 2021	SELL	$19.33 - $37.75 $13,724 - $26,802	-710 Closed	0 $0
Q4 2020 Jan 26, 2021	BUY	$24.48 - $42.47 $17,380 - $30,153	710 New	710 $18,000

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Clean Yield Group, based on Form 13F filings with the SEC.

Stay updated on Clean Yield Group with notifications on news.